<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02065284</url>
  </required_header>
  <id_info>
    <org_study_id>HBWP and RAS</org_study_id>
    <nct_id>NCT02065284</nct_id>
  </id_info>
  <brief_title>Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis</brief_title>
  <official_title>Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation on Walking and Cortical Activation in Patients With Multiple Sclerosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Kelvin and Eleanor Smith Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rhythmic Auditory Stimulation (RAS) is a music therapy technique that provides rhythmic
      auditory cues (like a beat) to help improve patients' movements, especially when walking.

      The purpose of this study is to compare the effect on walking performance of a home based
      walking program (HBWP) with Rhythmic Auditory Stimulation (RAS), to that of a HBWP without
      RAS, or to RAS without walking exercise.

      A second part of this study will assess the effects of Rhythmic Auditory Stimulation (RAS) on
      brain activity in patients with Multiple Sclerosis while performing mental imagery of
      walking.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved gait pattern on gait analysis</measure>
    <time_frame>8 weeks</time_frame>
    <description>To compare the effect on gait pattern of a walking program with Rhythmic Auditory Stimulation, to that of a walking program without Rhythmic Auditory Stimulation, or Rhythmic Auditory Stimulation without walking exercise.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved walk time on the timed 25 foot walk test</measure>
    <time_frame>8 weeks</time_frame>
    <description>To compare the effect on walking performance of a walking program with Rhythmic Auditory Stimulation, to that of a walking program without Rhythmic Auditory Stimulation, or Rhythmic Auditory Stimulation without walking exercise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved distance on the 2 minute walk test</measure>
    <time_frame>8 weeks</time_frame>
    <description>To compare the effect on walking performance of a walking program with Rhythmic Auditory Stimulation, to that of a walking program without Rhythmic Auditory Stimulation, or Rhythmic Auditory Stimulation without walking exercise.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>To assess changes in cortical activation induced by Rhythmic Auditory Stimulation in Multiple Sclerosis patients performing mental imagery of walking.</measure>
    <time_frame>8 weeks</time_frame>
    <description>Collect functional MRI images while performing guided imagery.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Multiple Sclerosis</condition>
  <condition>Ambulation Difficulty</condition>
  <arm_group>
    <arm_group_label>Walking-Rhythmic Auditory Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Walking daily with Rhythmic Auditory Stimulation (RAS) based music for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Walking- only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Walking daily with no Rhythmic Auditory Stimulation (RAS) based music for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rhythmic Auditory Stimulation (RAS)only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Listening to based music only daily for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rhythmic Auditory Stimulation (RAS)</intervention_name>
    <description>Rhythmic Auditory Stimulation (RAS) is a music therapy technique that provides rhythmic auditory cues (like a beat) to help improve patients' movements, especially when walking.</description>
    <arm_group_label>Walking-Rhythmic Auditory Stimulation</arm_group_label>
    <arm_group_label>Walking- only</arm_group_label>
    <arm_group_label>Rhythmic Auditory Stimulation (RAS)only</arm_group_label>
    <other_name>RAS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 18 years or older

          2. diagnosis of MS per Mc Donald criteria

          3. Ambulation Index score from 2 to 6 inclusive (clinically observable gait disturbance,
             whether the subject walks with no, unilateral, or bilateral support)

          4. spastic paresis is the main neurologic impairment causing the gait disturbance, per
             investigator's judgment.

        Exclusion Criteria:

          1. neurologic impairments other than spastic paresis (e.g. cerebellar ataxia or sensory
             ataxia), or non-neurologic impairments (e.g. musculoskeletal problems) play a major
             role in the subject's gait disturbance, per investigator's judgment;

          2. treatment for an MS exacerbation in the past 30 days;

          3. severe co morbidity precluding participation in the study per investigator's judgment
             (e.g. severe cardiac or respiratory failure);

          4. severe cognitive deficits precluding informed consent or preventing the subject from
             following study procedures safely

          5. contraindication to MRI such as severe claustrophobia and implanted devices such as
             neurostimulators, pacemakers, aneurysm clips etc.

          6. pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois A Bethoux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Neurological Institute Mellen Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Conklyn D, Stough D, Novak E, Paczak S, Chemali K, Bethoux F. A home-based walking program using rhythmic auditory stimulation improves gait performance in patients with multiple sclerosis: a pilot study. Neurorehabil Neural Repair. 2010 Nov-Dec;24(9):835-42. doi: 10.1177/1545968310372139. Epub 2010 Jul 19.</citation>
    <PMID>20643882</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2014</study_first_submitted>
  <study_first_submitted_qc>February 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2014</study_first_posted>
  <last_update_submitted>November 6, 2015</last_update_submitted>
  <last_update_submitted_qc>November 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MS</keyword>
  <keyword>Ambulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

